Phase I trial

June 4, 2020

Usually small trials, to find out how much of the drug is safe to give, what are the side effect, how does the body cope with the drug, does the tumour shrink.

Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect